China
· Delayed Price · Currency is CNY Winner Medical Statistics
Total Valuation
Winner Medical has a market cap or net worth of CNY 18.03 billion. The enterprise value is 17.36 billion.
| Market Cap | 18.03B |
| Enterprise Value | 17.36B |
Important Dates
The last earnings date was Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Winner Medical has 582.33 million shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | 582.33M |
| Shares Outstanding | 582.33M |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 70.43% |
| Owned by Institutions (%) | 14.65% |
| Float | 166.44M |
Valuation Ratios
The trailing PE ratio is 23.44 and the forward PE ratio is 17.67.
| PE Ratio | 23.44 |
| Forward PE | 17.67 |
| PS Ratio | 1.64 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | 18.08 |
| P/OCF Ratio | 10.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.20, with an EV/FCF ratio of 17.40.
| EV / Earnings | 22.52 |
| EV / Sales | 1.58 |
| EV / EBITDA | 9.20 |
| EV / EBIT | 14.30 |
| EV / FCF | 17.40 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.86 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | 2.73 |
| Interest Coverage | 23.31 |
Financial Efficiency
Return on equity (ROE) is 6.67% and return on invested capital (ROIC) is 8.95%.
| Return on Equity (ROE) | 6.67% |
| Return on Assets (ROA) | 4.18% |
| Return on Invested Capital (ROIC) | 8.95% |
| Return on Capital Employed (ROCE) | 8.81% |
| Weighted Average Cost of Capital (WACC) | 4.74% |
| Revenue Per Employee | 695,270 |
| Profits Per Employee | 48,621 |
| Employee Count | 15,642 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 2.89 |
Taxes
In the past 12 months, Winner Medical has paid 238.58 million in taxes.
| Income Tax | 238.58M |
| Effective Tax Rate | 22.47% |
Stock Price Statistics
The stock price has decreased by -35.32% in the last 52 weeks. The beta is 0.18, so Winner Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -35.32% |
| 50-Day Moving Average | 33.55 |
| 200-Day Moving Average | 37.92 |
| Relative Strength Index (RSI) | 38.79 |
| Average Volume (20 Days) | 3,820,692 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Winner Medical had revenue of CNY 11.02 billion and earned 770.89 million in profits. Earnings per share was 1.32.
| Revenue | 11.02B |
| Gross Profit | 5.19B |
| Operating Income | 1.21B |
| Pretax Income | 1.06B |
| Net Income | 770.89M |
| EBITDA | 1.66B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | 1.32 |
Balance Sheet
The company has 4.19 billion in cash and 2.73 billion in debt, giving a net cash position of 1.47 billion or 2.52 per share.
| Cash & Cash Equivalents | 4.19B |
| Total Debt | 2.73B |
| Net Cash | 1.47B |
| Net Cash Per Share | 2.52 |
| Equity (Book Value) | 12.54B |
| Book Value Per Share | 20.09 |
| Working Capital | 4.04B |
Cash Flow
In the last 12 months, operating cash flow was 1.76 billion and capital expenditures -766.22 million, giving a free cash flow of 997.62 million.
| Operating Cash Flow | 1.76B |
| Capital Expenditures | -766.22M |
| Depreciation & Amortization | 442.42M |
| Net Borrowing | -14.68M |
| Free Cash Flow | 997.62M |
| FCF Per Share | 1.71 |
Margins
Gross margin is 47.07%, with operating and profit margins of 11.01% and 6.99%.
| Gross Margin | 47.07% |
| Operating Margin | 11.01% |
| Pretax Margin | 9.63% |
| Profit Margin | 6.99% |
| EBITDA Margin | 15.03% |
| EBIT Margin | 11.01% |
| FCF Margin | 9.05% |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 2.40%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 2.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 71.21% |
| Buyback Yield | -0.30% |
| Shareholder Yield | 2.11% |
| Earnings Yield | 4.27% |
| FCF Yield | 5.53% |
Stock Splits
The last stock split was on June 2, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Winner Medical has an Altman Z-Score of 4.06 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.06 |
| Piotroski F-Score | 8 |